TipRanks
Go Ultimate55% OFF

Verrica Pharmaceuticals (VRCA) Revenue

Verrica Pharmaceuticals Revenue

Verrica Pharmaceuticals had a revenue of 5.86M in the quarter ending Jun 30, 2026, with 16.70%. This bring the company's revenue in the last twelve months to 30.32M, Decreased 18.41%. In the fiscal year ending Dec 31, 2025, Verrica Pharmaceuticals had annual revenue of 35.58M with 370.22% growth.

Revenue (ttm)
30.32M
Revenue Growth
106.21%
P/S Ratio
1.62
Revenue/Employee
$468,118
Employees
76
Market Cap
$57.55M

Revenue Chart

Verrica Pharmaceuticals Revenue - Annual

010M20M30M40M12.00M9.03M5.12M7.57M35.58M201720182019202020212022202320242025
Revenue History
Download to Excel
VRCA revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202535.58M28.01M370.22%
Dec 31, 20247.57M2.44M47.66%
Dec 31, 20235.12M-3.91M-43.27%
Dec 31, 20229.03M-2.97M-24.73%
Dec 31, 202112.00M12.00M―
Dec 31, 20200.000.00―
Dec 31, 20190.000.00―
Dec 31, 20180.000.00―
Dec 31, 20170.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
VRCA30.32M
ELUT12.13M
EVAX7.49M
LIMN0.00